Stroke Mitigation in A-fib Reasoning Tool for Shared Decision Making


About this study

The purpose of this study is to assist patients and clinicians weigh the potential harms and benefits of different treatment options for atrial fibrillation.  The plan is to develop an evidence-based decision aid for use in clinical encounters. The goal is to promote evidence-based patient-centered care. Ideally, this care should reflect the research evidence about treatment options for atrial fibrillation. It should also reflect the values and preferences of the informed patient.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients
    • Adults ≥ 18 years
    • Appointment to discuss treatment options for atrial fibrillation
  • Clinicians
    • Clinicians who meet with patients to discuss treatment options for atrial fibrillation
  • PAG Members
    • Adults ≥ 18 years
    • Member of the KER Unit PAG

Exclusion Criteria:

  • Patients
    • Major barriers to providing informed consent (i.e. dementia, severe hearing or visual impairment)
  • Clinicians
    • None
  • PAG Members
    • None


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Juan Brito Campana, M.B.B.S.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer